Reports- Cancer Immunotherapy Market Trends | Page 4
6.7.2.2 Colorectal cancer
6.7.3 Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin
(2011-2016)
6.7.4 Main Business/Business Overview
6.8 Merck
6.8.2 Cancer Immunotherapy Product Type, Application and Specification
6.8.2.1 Melanoma
6.8.2.2 Colorectal cancer
6.8.3 Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.2 Cancer Immunotherapy Product Type, Application and Specification
6.9.2.1 Melanoma
6.9.2.2 Colorectal cancer
6.9.3 Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.9.4 Main Business/Business Overview
6.10 Pfizer
6.10.2 Cancer Immunotherapy Product Type, Application and Specification
6.10.2.1 Melanoma
6.10.2.2 Colorectal cancer
6.10.3 Pfizer Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.10.4 Main Business/Business Overview
6.11 Seattle Genetics
6.12 Peregrine Pharmaceuticals
6.13 Viralytics Ltd
6.14 Immunomedics
7 Cancer Immunotherapy Manufacturing Cost Analysis
7.1 Cancer Immunotherapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Immunotherapy
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cancer Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend